articleNature BiotechnologyMay 30, 2003Closed access

Development of potent monoclonal antibody auristatin conjugates for cancer therapy

Seagen (United States)

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

No related works found for this paper.

Funding